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Abstract Cardiac troponin I, the inhibitory subunit of the
heterotrimeric cardiac troponin (cTn) complex is phosphorylated
by protein kinase A at two serine residues located in its heart-
specific N-terminal extension. This flexible arm interacts at
different sites within cTn dependent on its phosphorylation
degree. Bisphosphorylation is known to induce conformational
changes within cTnI which finally lead to a reduction of the
calcium affinity of cTnC. However, as we show here, the
bisphosphorylated cTnI arm does not interact with cTnC, but
with cTnT and/or cTnI. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The inhibitory subunit (cTnI) of the heterotrimeric cardiac
troponin complex (cTn) is phosphorylated upon L-adrenergic
stimulation by protein kinase A (PKA) [1]. Phosphorylation
occurs at serine 22 and 23 (human sequence) [2], which are
located in the 32 amino acid long £exible N-terminal exten-
sion of cTnI. Sequential phosphorylation and sequential de-
phosphorylation by protein phosphatase 2A (PP2A) lead to
four cTnI forms, one bis- and non-phosphorylated form and
two monophosphorylated forms [3,4]. Bisphosphorylation is
known to reduce the calcium a⁄nity of cardiac troponin C
(cTnC) [5,6] and, as shown recently, reduces the maximal
actomyosin ATPase activity [7]. The molecular mechanism is
not known. Upon phosphorylation conformational changes
occur in cTn, which seem to be accompanied by movements
of the £exible N-terminal cTnI arm. Liao et al. [8] and Dong
et al. [9] described a conformational change in cTnI to a more
globular shape due to bisphosphorylation at Ser22 and 23. We
observed a change in the secondary structure in isolated cTnI
upon monophosphorylation at either serine residue using cir-
cular dichroism (CD) spectroscopy [10]. Furthermore, mono-
phosphorylation and, to an even larger extent, bisphosphor-
ylation reduce the a⁄nity of cTnI towards the other cTn
subunits [11], also indicating conformational changes within
cTnI. 31P-Nuclear magnetic resonance (NMR) spectra of cTn
revealed that phosphate groups of mono- and bisphosphory-
lated cTnI are located in di¡erent chemical environments [12].
In the monophospho form, phosphoserine residue (PSer)23,
the phosphate group interacts with a preceding arginine side-
chain, thus stabilising the reversed turn formed by the phos-
phorylation region [13]. In monophosphorylated PSer22 the
phosphate group is in a nearly identical chemical environment
as free phosphoserine indicating that the phosphate group can
rotate freely and does not interact with other groups [13].
Thus, in both monophosphorylated forms the phosphoryla-
tion region does not interact either with the body of cTnI
or with cTnT or cTnC. When cTnI is bisphosphorylated
31P-NMR measurements reveal a weak interaction of the
phosphorylation region within cTn [12^14]. An interaction
site in the N-terminal domain (N-DOM) of cTnC would allow
the direct in£uence of calcium binding properties of cTnC.
However, as we will show here, the bisphosphorylated N-ter-
minal extension of cTnI does not interact with cTnC, but with
cTnT and/or cTnI.
2. Materials and methods
2.1. Construction of plasmids
The cDNAs encoding human cardiac troponin C (hcTnC) and the
major isoform of hcTnT were derived from clone TC1 [15] and from
clone HCTNT2 [16], respectively. The cDNA for hcTnC was sub-
cloned into the pET3c vector [13] and the one for hcTnT into the
pSBETc vector [17,18] thus serving as templates for the generation of
the hcTnC domains (hcTnC-N-DOM and hcTnC-C-DOM) and the
C-terminal domain of hcTnT (hcTnT-C-DOM), respectively. The
primers for the generation of the hcTnC-N-DOM construct were 5P-
GAA TTC ATA TGG ATG ACA TCT ACA AGG CTG-3P (sense)
and 5P-AAG CTT GGA TCC CTA AGA TTT CCC TTT GCT GTC
GTC C-3P (antisense); those for the hcTnC-C-DOM construct were
5P-GAA TTC ATA TGG TTC GGT GCA TGA AGG ACG-3P
(sense) and 5P-AAG CTT GGA TCC CTA CTC CAC ACC CTT
CAT GAA CTC-3P (antisense) and those for the hcTnT-C-DOM
construct were 5P-GCG CGA ACA TAT GGG GGG TTA CAT
CCA GAA GCA G-3P (sense) and 5P-TGA GGA TCC TCA TTT
CCA GCG CCC GGT GAC TT-3P (antisense). All sense and anti-
sense primers contained the NdeI and the BamHI restriction sites,
respectively, for subcloning into the NdeI^BamHI site of the pSBETc
vector. The sequence of all derived clones was con¢rmed by auto-
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mated sequencing with the Applied Biosystems 373 DNA Sequencer
using the ABI Taq DyeDeoxy terminator cycle sequencing ready re-
action kit.
2.2. Protein expression
cTn subunits and their constructs were expressed in Escherichia coli
BL21(DE3). Cells were grown in NZCYM medium with 50 Wg/ml
ampicillin (for hcTnI-wild type (WT), hcTnC-WT) or 50Wg/ml kana-
mycin (for hcTnT-WT, hcTnT-C-DOM, hcTnC-N-DOM and hcTnC-
C-COM) until OD600 = 0.6. 4 h after induction with 1 ml of 0.4 M
isopropyl-L-thiogalactoside solution/l medium cells were harvested by
centrifugation and stored at 320‡C. Expression was checked with
sodium dodecyl sulphate^polyacrylamide gel electrophoresis (SDS^
PAGE) according to Sambrook et al. [19].
2.3. Protein puri¢cation
hcTnI-WT and hcTnC-WT were puri¢ed as described by Rei¡ert et
al. [11] and Babu et al. [20], respectively. For puri¢cation of hcTnT-
WT, the pellet obtained from a 3 l culture was resuspended in 20 ml
25 mM Tris^HCl, pH 7.5, 20% (w/v) sucrose, 1 mM EDTA, 0.3 mM
phenylmethylsulfonyl £uoride (PMSF), 0.2 M NaCl, 5 Wg/ml N-tosyl-
L-phenylalanine chloromethyl ketone and 5 Wg/ml NK-p-tosyl-L-lysine
chloromethyl ketone and stored at 380‡C. Cells were disrupted by
using a French Press (Aminco). The suspension was incubated at 4‡C
for 1 h after adding pure urea (¢nal concentration: 5 M) and Triton
X-100 (¢nal concentration: 0.1% (v/v)). After centrifugation (1 h, 4‡C,
27 000Ug) the supernatant was diluted 10U with 50 mM Tris^HCl,
pH 7.5, 5 mM CaCl2, 1 mM MgCl2, 1 mM dithiothreitol (DTT) and
5 M urea and subsequently was incubated at 4‡C for 2 h with DE52
material (Whatman) equilibrated with the same bu¡er. After washing
o¡ unbound proteins, the suspension was poured into a column and
bound protein was eluted with 1 M NaCl added to the bu¡er. The
protein containing fractions were applied onto 400 ml G75 material
(Pharmacia) equilibrated with 50 mM Tris^HCl, pH 7.5, 0.5 M NaCl,
5 mM CaCl2, 1 mM MgCl2 and 2 mM DTT. After elution the purity
of collected hcTnT fractions was checked by SDS^PAGE. hcTnC-N-
DOM comprising amino acids 1^93 was puri¢ed from a bacterial
pellet obtained from a 2 l culture following the procedure as described
for hcTnC-WT. hcTnC-C-DOM (amino acids 81^161) was puri¢ed
from pellets obtained from a 6 l culture. Cells were lysed in 90 ml
50 mM Tris^HCl, pH 8.0, 1 mM EDTA, 0.5 mM PMSF, 25% (w/v)
sucrose and 1 mM DTT by using the French Press. After centrifuga-
tion (27 000Ug, 4‡C, 30 min), urea, MgCl2 and KCl were added to
the supernatant to ¢nal concentrations of 8 M, 2 mM and 50 mM,
respectively. Urea was removed step-wise and puri¢cation was per-
formed as described for hcTnC-WT. For puri¢cation of hcTnT-C-
DOM comprising amino acids 186^291, cells obtained from 2 l bac-
terial culture were disrupted in 50 mM Tris^HCl, pH 7.5, 5 mM
CaCl2, 1 mM MgCl2 and 1 mM DTT by using the French Press.
Ammonium sulphate was added to the suspension up to a ¢nal con-
centration of 22.5% (w/v). After stirring for 1 h at 4‡C and centrifu-
gation (4‡C, 20 000Ug, 30 min) ammonium sulphate was added to the
supernatant up to a ¢nal concentration of 62% (w/v) and the incuba-
tion and centrifugation steps were repeated. The pellet was resus-
pended in 50 mM Tris^HCl, pH 7.5, 5 mM MgCl2, 1 mM DTT
and pre-puri¢ed by cation exchange chromatography as on CM52-
material (Whatman) as described for the puri¢cation of hcTnT-WT.
Collected protein fractions were dialysed in 1 mM K2HPO4/KH2PO4,
pH 6.9, 100 mM KCl, 2 mM DTT and then applied onto 100 ml
hydroxyapatite, equilibrated with the same phosphate bu¡er. Protein
was eluted with 400 mM K2HPO4, 100 mM KCl, 2 mM DTT.
The purity of all proteins and calcium-dependent mobility of
hcTnC-WT, hcTnC-C-DOM and hcTnC-C-DOM were checked by
SDS^PAGE. The proteins except hcTnI-WT were stored at 320‡C.
hcTnI-WT was kept on ice.
2.4. Mass determination
The mass of all mutant proteins was determined using electrospray
ionisation-mass spectrometry (ESI-MS), TSQ 7000 (Finnigan). Dur-
ing 2 s ions with a mass/charge ratio of 200^2500 were measured. All
mass/charge data were analysed by the BioMass software [21].
2.5. Phosphorylation of hcTnI-WT
200 nmol of hcTnI-WT was phosphorylated with 200 WU/ml of the
recombinant catalytic subunit of PKA [22] for 1 h at 30‡C in 20 mM
3-morpholino-propane sulfonic acid (MOPS), pH 7.0, 0.3 M KCl,
5 mM MgCl2, 2 mM DTT and 1 mM ATP. The phosphorylation
degree was controlled by isoelectric focusing (IEF) and subsequent
scanning densitometry according to Ardelt et al. [23]. The total
amount of protein bound phosphate was determined according to
Stull and Buss [24].
2.6. Reconstitution of the various troponin complexes
hcTn complexes were formed by combining recombinant hcTnI-
WT, hcTnT (hcTnT-WT or hcTnT-C-DOM) and hcTnC (hcTnC-
WT, hcTnC-N-DOM or hcTnC-C-DOM) in a molar ratio of 1:1:1
in 50 mM Tris, pH 7.5, 6 M urea, 0.5 M NaCl, 5 mM CaCl2 and
5 mM DTT. After incubation for 2 h at room temperature urea was
reduced step-wise from 6 to 4 to 2 and ¢nally to 0 M in the same
bu¡er with 1 M KCl. Then the KCl concentration was reduced to 0.3
M. Non-complexed subunits and heterodimers were removed by gel
¢ltration on 400 ml Sephadex G-75 with 10 mM MOPS, pH 7.0, 0.5
M KCl, 1.5 mM CaCl2 and 1 mM DTT. The ratio of subunits present
in the various troponin complexes were controlled by SDS^PAGE
and by analytical gel ¢ltration on Sephadex 200 PC3.2/30 by using
the Smart-system (Pharmacia). Calibration was performed by using
the ‘High/Low Molecular Weight Gel Calibration Kit’ (Pharmacia).
2.7. Molecular modelling
For molecular modelling INSIGHT (User Guides 1995 MSI, San
Diego, CA, USA) was used on a Silicon Graphics Indigo2. The solu-
tion structure of cTnC [25] was used as template to generate cTnC-N-
DOM and cTnC-C-DOM. Coordinates were obtained from the
Brookhaven Data Bank (entry code: 1AJ4).
2.8. 31P-NMR spectroscopy
The reconstituted Tn complexes were dialysed in 10 mM
NH4HCO3 and dried in vacuo. The dried proteins were dissolved in
700 Wl D2O containing 20 mM MOPS, pH 7.0, 0.5 M KCl and 2 mM
DTT and either 100 WM CaCl2 or 1 mM EGTA. The pH was not
corrected for D2O. pH was controlled before and after each measure-
ment. Since small pH di¡erences (even 6 0.1 pH-units) result in
changes of the chemical shift of 31P-NMR signals [12], inorganic
phosphate dissolved in the same bu¡er was added to each sample
as an internal pH standard. For assignment of the 31P-NMR-signals
in di¡erent spectra the dependence of the chemical shifts on pH of Pi
and phosphoserine alone or added to the cTn solutions was used [12].
Spectra were recorded on a 600 MHz (proton frequency) Bruker
NMR-spectrometer at room temperature. Chemical shifts are quoted
relative to external 85% H3PO4 in H2O.
3. Results
The masses of the WT and mutant proteins determined by
ESI-MS coincide with the masses calculated from the amino
acid sequences (Table 1). The correct size of the hcTn sub-
units, their constructs and the purity of the isolated proteins
have additionally been veri¢ed by SDS^PAGE (Fig. 1). Large
Table 1
Characteristics of cTn complexes and their subunits
Protein Mass (kDa) Retention time
determined calculatedb (min)a
hcTnT-WT 34.5 34.6 40.4
hcTnI-WT 24.0 24.0 42.2
hcTnC-WT 18.4 18.4 42.8
hcTn n.d. 77.0 32.9
hcTnC-N-DOM 10.5 10.4 47.9
hcTn-hcTnC-N-DOM n.d. 69.0 34.3
hcTnC-C-DOM 9.3 9.3 48.6
hcTn-hcTnC-C-DOM n.d. 67.9 35.4
hcTnT-C-DOM 12.5 12.6 46.6
hcTn-hcTnT-C-DOM n.d. 55 36.7
n.d., not determined.
aRetention times were determined twice, mean values are given, a
di¡erence in retention time of 0.3 min is signi¢cant.
bBased on the cDNA sequence.
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changes in electrophoretic mobility dependent on calcium sat-
uration was observed for hcTnC-C-DOM (Fig. 1, lanes 1 and
2), only a small e¡ect on mobility was obtained using calcium-
free and calcium-saturated hcTnC-N-DOM and cTnC-WT
(Fig. 1, lanes 3^6).
The formation of cTn complexes containing the subunits in
a molar ratio of 1:1:1 had been veri¢ed by analytical gel
¢ltration which yielded a single symmetrical peak at a reten-
tion time (Table 1) consistent with the molecular mass of the
various complexes. These complexes were phosphorylated by
PKA and the phosphorylation degree of cTnI was controlled
by IEF (Fig. 2, inserts). The intensity ratio of the mono- and
bisphospho-cTnI bands, obtained by scanning densitometry,
is comparable to the ratio of the peak areas of the appropriate
31P-NMR signals (not shown). Only those cTn constructs
which contained either a mixture of mono- and bisphosphory-
lated or exclusively bisphosphorylated cTnI were used for 31P-
NMR measurements. Over-phosphorylated complexes, which
were obtained seldom, were rejected. In the 31P-NMR spectra
of the selected cTn complexes no other signals than those for
PSer22 and 23 have been detected indicating that only Ser22
and 23 have been phosphorylated by PKA.
31P-NMR spectra of native bovine cTn and of correctly
reconstituted hcTn composed of WT subunits both containing
a mixture of di¡erent cTnI phosphoforms typically show three
signals comparable to those in Fig. 2A,B (see also chemical
shifts in Table 2). As described formerly for the native protein
[12] one signal each had been assigned to the monophospho
forms, PSer23 (3.91 ppm) and PSer22 (3.77 ppm) and one
signal (3.51 ppm) to both phosphate groups in bisphosphory-
lated cTnI (bcTn, Table 2). The di¡erence in chemical shift is
due to di¡erent apparent pKa values of the phosphate groups
in the mono- and bisphospho-cTnI forms [12]. This indicates
that the phosphate groups are located in di¡erent chemical
environments. The phosphate group in the monophospho
form PSer22 behaves like free phosphoserine, the one bound
to Ser23 interacts with the preceding arginine side chain
present in the consensus sequence for PKA resulting in a
chemical shift to higher ppm values [12].
Upon bisphosphorylation both signals shift to a nearly
identical lower ppm value (Table 2). This signal is observed
exclusively when bisphosphorylated cTnI is present in a cor-
rectly folded heterotrimeric cTn complex, not in binary com-
plexes or in the isolated cTnI subunit. Therefore, it represents
the interaction of the phosphorylation region in the N-termi-
nal arm of cTnI with another cTn subunit [12] and had been
called the ‘interaction signal’ (IS).
To reveal if cTnC is the interaction partner for the bisphos-
phorylated cTnI arm, hcTn complexes containing either the
N-terminal or C-terminal part of hcTnC have been examined
by 31P-NMR spectroscopy (Fig. 2A,B). Since both complexes
have not been completely bisphosphorylated as shown by IEF
(see insert Fig. 2B), signals for each monophospho form at
3.71 and 3.49 ppm (spectrum A; Table 2) and 3.85 and 3.68
ppm (spectrum B; Table 2) have been obtained. The di¡er-
ences in chemical shift of the PSer23 and PSer22 signals in the
two spectra, A and B, are due to minor di¡erences in pH as
can be seen by concomitant shifts of the Pi signal (Table 2).
This is also true for the IS which surprisingly has been ob-
served with both cTn complexes (3.05 ppm (Fig. 2A), 3.36
ppm (Fig. 2B); Table 2). The presence of the IS in both
spectra indicates that either the bisphosphorylated N-terminal
extension does not interact with cTnC or the N-terminal and
C-terminal halves replace each other in the troponin complex.
Thus, the backbones of the two cTnC halves were superim-
posed and root mean square (RMS) £uctuations averaged
Fig. 1. SDS^PAGE of di¡erent cTn complexes, calcium-saturated
and calcium-free. In lane 1 and 2, cTn complexes containing
hcTnC-C-DOM calcium-saturated and calcium-free, respectively,
have been applied. Separation of cTn complexes containing hcTnC-
N-DOM in calcium or in EGTA are shown in lane 3 and 4, respec-
tively. As a control hcTn-WT has been applied in calcium or
EGTA containing bu¡er on lane 5 and 6, respectively. As standard,
bovine cardiac troponin has been applied on lane 7. A molecular
weight marker, cTnT-C-DOM and cTn containing cTnT-C-DOM
are applied on lane 8, 9 and 10, respectively. In all lanes about 10
Wg of protein has been applied.
Table 2
Chemical shifts of the 31P-NMR signals
Protein Chemical shift in ppm
PSer23 PSer22 PSer22/23 Pi
bcTn 3.91 3.77 3.51 2.00
hcTn-cTnC-N-DOM 3.71 3.49 3.05 1.55
hcTn-cTnC-C-DOM 3.85 3.68 3.36 1.81
hcTn-cTnT-C-DOM ^ ^ 3.40 1.85
bcTn means cardiac troponin, isolated from bovine heart according
to Beier et al. [14], Pi is inorganic phosphate, PSer22 and PSer23
designate the signals resulting from the monophospho forms of
cTnI and PSer22/23 the signal obtained with the bisphosphorylated
protein.
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over the backbone atoms were calculated. The two halves are
clearly di¡erent (RMSs 12 Aî ; Fig. 3). Also the orientation of
the central helix, which is involved in the binding of cTnI, is
completely di¡erent in both cTnC halves upon optimal super-
imposition of the two EF-hands. Additionally, only cTn com-
plexes have been formed which contain 1 mol cTnC-N- or -C-
DOM per 1 mol of cTnT and cTnI as shown by analytical gel
¢ltration (compare retention times in Table 1). Thus it can be
concluded that the bisphosphorylated cTnI extension interacts
with a cTn subunit other than cTnC.
To decide in which region of cTn the interaction might
occur, a N-terminally truncated hcTnT, hcTnT-C-DOM (ami-
no acids 185^291), was reconstituted with hcTnI-WT and
hcTnC-WT to a ternary hcTn complex. The 31P-NMR spec-
trum again shows the IS (Fig. 2C) indicating that an interac-
tion might occur within the sequence stretch of 185^291 of
cTnT. Furthermore, all spectra recorded with cTn complexes
in calcium-saturated and calcium-free state were identical
(therefore only one set of data is shown in Fig. 2).
4. Discussion
31P-NMR spectroscopy is an excellent tool to observe di-
rectly each single phosphate group in a protein when present
in di¡erent chemical environments. Using this method we
characterised the di¡erent phospho forms of cTnI within the
complex, which together with data from other experiments led
to the conclusion that the heart-speci¢c N-terminal extension
of cTnI is a £exible arm which alters the interaction partner
within the cTn molecule dependent on its phosphorylation
degree [12^14]. In contrast to the monophosphorylated cTnI
arm, both, the non- and the bisphosphorylated cTnI arm seem
to make contacts within the cTn complex. As shown by CD
spectroscopy changes in the backbone of isolated cTnI were
observed upon monophosphorylation, which led to the con-
clusion that the non-phosphorylated extension interacts with
cTnI itself and is released after monophosphorylation [10].
Other groups described an interaction of the non-phosphory-
lated cTnI-N-terminal arm with the C-DOM of cTnC using
cTnC and fragments of cTnI or vice versa [26^28]. These
contradictions are probably caused by the use of isolated sub-
units on the one hand and binary complexes with peptides on
the other.
In accordance with these groups [26^28], we could not de-
tect an interaction of the bisphosphorylated cTnI arm with
cTnC in the heterotrimeric cTn complex as shown here. As
with native cTn the IS has been obtained with both cTn con-
structs containing either cTnC-N-DOM or cTnC-C-DOM. If
the interaction partner would be, for example, cTnC-N-DOM,
Fig. 2. 31P-NMR measurements of the various cTn complexes con-
taining cTnI phosphorylated by PKA. 31P-NMR spectra have been
recorded with a spectral width of 2332 Hz. As internal pH standard
inorganic phosphate (Pi) was used. A: 15 mg cTn with cTnC-N-
DOM (1.8 mol P/mol protein; 48 000 scans) in NMR- bu¡er; B: 20
mg cTn with cTnC-C-DOM (1.6 mol P/mol protein; 30 000 scans;
C: 15 mg cTn with cTnT-C-DOM (2.0 mol P/mol protein, 11 080
scans). IS designates the interaction signal and 23, 22 phosphoser-
ines in position 23 or 22. The inserts show IEF gels, where 4 Wl
cTnI (10 Wg) isolated from cTn complexes by high performance liq-
uid chromatography as described by Swiderek et al. [30] have been
applied (lanes 2). As standard, bovine cTnI isolated from bovine
heart [14] has been applied (lanes 1). B, M and D designate
bisphosphorylated, monophosphorylated and non-phosphorylated
cTnI, respectively.
Fig. 3. Superimposition of cTnC-N-DOM and cTnC-C-DOM.
Superimposed backbones of hcTnC-N-DOM and hcTnC-C-DOM
are dragged apart and presented as ribbon.
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one would expect the IS in the 31P-NMR spectrum obtained
with the cTn complex containing cTnC-N-DOM, but not in
the spectrum with cTn containing cTnC-C-DOM. Vice versa
the IS should be observed in the spectra of cTn with cTnC-C-
DOM, but not in the spectrum of cTn with cTnC-N-DOM, if
the interaction partner is the C-DOM of cTnC.
The attractive conclusion of Gaponenko et al. and Abott et
al. [27,28] that the release of the cTnI arm by phosphorylation
of cTnI at Ser22 and 23 directly leads to the reduction of the
calcium a⁄nity of cTnC does not take into account that al-
ready monophosphorylation releases the cTnI arm [10,12].
Although e¡ects of monophosphorylation on the a⁄nity of
cTnI to cTnT and cTnC [11] and on the actomyosin ATPase
activity [7] have been described, an in£uence on cTnC-calcium
a⁄nity could be detected exclusively upon bisphosphorylation
of cTnI [5^7,10]. Therefore changes induced by bisphosphor-
ylation within the troponin complex including the interaction
of the bisphosphorylated cTnI arm are decisive to alter the
calcium a⁄nity of cTnC. These observations and the results
presented here favour an indirect propagation of the PKA
signal as has also been proposed by Chandra et al. [29].
They postulated an interaction of the bisphosphorylated
cTnI arm with cTnI itself. Such an interaction cannot be ex-
cluded by the 31P-NMR experiments presented here, but
might also occur within the C-DOM of cTnT (186^261). Since
chemical shift or half line width of the IS is not altered upon
calcium binding or release, the interaction takes place in a
calcium insensitive region. Furthermore, binary TI or IC com-
plexes are not su⁄cient to provide the ‘correct’ environment
allowing the interaction of the bisphosphorylated cTnI arm.
[12], but a ternary complex with either the C-terminal part of
cTnT or one of the two cTnC constructs is.
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